François Guilhot, Brian Druker, Richard A. Larson, Insa Gathmann, Charlene So, Roger Waltzman, Stephen G. O’Brien. High rates of durable response are achieved with imatinib after treatment with interferon α plus cytarabine: results from the International Randomized Study of Interferon and STI571 (IRIS) trial. haematol [Internet]. 2009Dec.7 [cited 2024Nov.25];94(12):1669-75. Available from: https://haematologica.org/article/view/5431